XLV, the Health Care Select Sector SPDR ETF, has turned the page again — the short rebuild flagged a week ago has unwound, with short sellers paring back even as the ETF slips modestly on the week.
The reversal in positioning is the clearest story this week. Short interest has fallen roughly 5% over the past seven days to 5.6% of free float, retracing a portion of the aggressive rebuild that ran through late August. That rebuild peaked around August 24-26, when SI touched 5.95% and the ORTEX short score climbed above 55. Both have since pulled back — the short score dropped to 51.9 by September 1, giving up nearly all the gains made over the prior two weeks. This isn't noise; it's a second reversal within a month, suggesting shorts are trading this ETF tactically rather than holding a structural conviction.
The borrow market tells the same retreating story. Availability has loosened sharply — from a tight 74% on August 24 to 171% now, meaning there is nearly twice as much borrow supply as current short interest demands. That's a meaningful swing back toward comfort. Cost to borrow has eased to 0.53%, down roughly 9% on the week and sitting near the low end of its one-month range. When short sellers were rebuilding aggressively two weeks ago, availability compressed and borrow costs crept up. The reversal of both metrics in tandem confirms that covering activity, not fresh shorts, has driven the week's flow. Borrow conditions are now firmly in the normal range, and there is no squeeze dynamic in sight.
Options positioning offers a mild counterpoint to the easing short-side pressure. The put/call ratio has held stubbornly elevated at 1.44, running just above its 20-day average of 1.41 — a posture that has barely shifted through August. The 52-week range on the PCR spans from 0.47 to 2.67, so the current reading is neither extreme nor unusual, but the persistence of above-1 puts-to-calls for weeks on end suggests that hedging demand remains a constant background feature of XLV positioning. That's consistent with the ETF's defensive role: investors in healthcare often hold puts as portfolio insurance regardless of their directional view on the sector.
The price action adds context. XLV closed at $171.67, down about 2% on the week after a strong August that delivered a 5.6% one-month gain. The weekly dip is modest, and the broader trend remains constructive for longs. Institutional ownership looks stable through June — Managed Account Advisors holds the largest disclosed stake at 9% of shares. JPMorgan trimmed roughly 2.7 million shares in the quarter, while Goldman added 1.3 million, a modest divergence among the large holders that doesn't point to any concentrated exit.
The setup heading into September is one of easing short-side pressure against a backdrop of persistent options hedging — neither an aggressive bear thesis nor a clean bull setup, but a market that continues to use this ETF as a two-way tactical vehicle. What to watch next is whether the short score stabilises near 50 or resumes its August pattern of sharp swings, which would signal whether the current covering is a pause or a more durable retreat.
See the live data behind this article on ORTEX.
Open XLV on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
